Skip to content
Saverna Therapeutics AG logo

Saverna Therapeutics AG Alternatives & Competitors

4 companies similar to Saverna Therapeutics AG — Saverna Therapeutics aims to discover highly active, selective and cell-permeabl...

Companies similar to Saverna Therapeutics AG

Envisagenics logo — alternative to Saverna Therapeutics AG

Envisagenics

Artificial Intelligence, High Performance Computing, and RNA sequencing data to find cures...

1910 Genetics logo — alternative to Saverna Therapeutics AG

1910 Genetics

Advancing small and large molecule drug discovery with a multimodal AI platform powered by...

Lantern Pharma Inc. (Nasdaq: LTRN) logo — alternative to Saverna Therapeutics AG

Lantern Pharma Inc. (Nasdaq: LTRN)

Leveraging Artificial Intelligence to Rescue and Develop Cancer Therapies

Iambic logo — alternative to Saverna Therapeutics AG

Iambic

Better technology for better medicines | Nasdaq: IAM

About Saverna Therapeutics AG

Saverna Therapeutics is a Swiss pharmaceutical start-up company founded in 2017 with the focus on developing small molecule drugs to target non-coding RNA for treating diseases with high unmet need. Founded by four former lab heads at Novartis, Switzerland, the company aims to leverage their expertise in a specialized...

Business keywords

Pharmaceutical Industry, Drug Discovery, Small Molecule Drugs, Non-coding RNA, Swiss Start-up, Disease Treatment, RNA-targeting Compounds, Inflammation, Cancer Research, Infection Treatment, Biomedical Research, Precision Medicine, Therapeutics Development

Frequently Asked Questions

Companies similar to Saverna Therapeutics AG include Envisagenics, 1910 Genetics, Lantern Pharma Inc. (Nasdaq: LTRN), Iambic. They work in AI and Health and Wellness and share Saverna Therapeutics AG's focus on drug discovery, cancer research and precision medicine.
Bounce Watch lists 4 companies that share Saverna Therapeutics AG's industries and are closest to it in business tags, services, target customers, business model and size.
Saverna Therapeutics is a Swiss pharmaceutical start-up company founded in 2017 with the focus on developing small molecule drugs to target non-coding RNA for treating diseases with high unmet need. Founded by four former lab heads at Novartis, Switzerland, the company aims to leverage their expertise in a specialized...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Saverna Therapeutics AG: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Compiled from the BounceWatch company index. We last looked at Saverna Therapeutics AG on 11 Sep 2024. The 4 companies listed here were last checked between 2 Apr 2026 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout